- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05096156
Evaluation of Wear Experience With Daily Contact Lenses
November 6, 2023 updated by: Jennifer Fogt, Ohio State University
Evaluation of Wear Experience With PRECISION1® Contact Lenses in Biofinity® Contact Lens Wearers
To evaluate the wear experience of current monthly replacement contact lens wearers after they have been fit into a daily disposable contact lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Optometry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Currently wear Biofinity® monthly replacement spherical contact lenses.
- Distance visual acuity of 20/25 or better with current contact lenses.
- Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the PI).
- Ability to give informed consent.
- Willing to spend time for the study, which includes attending two study visits and wearing contact lenses on days between study visits.
Exclusion Criteria:
- No current ocular inflammation or infection.
- Not currently pregnant or lactating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All participants are fit with the study daily disposable lenses
All subjects are re-fit into their habitual monthly replacement contact lenses.
Subjects are requested to wear the lenses for one week, for a minimum of at least 6 hours per day for 5 days.
Upon return, subjects are refit into the daily disposable contact lenses.
|
Soft, spherical contact lens used to correct distance vision.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Assessment of Precision1® Daily Disposable Contact Lens
Time Frame: 2 weeks
|
Contact Lens Dry Eye Questionnaire (CLDEQ) survey (0-37, with higher scores related to higher symptoms)
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2021
Primary Completion (Actual)
November 17, 2021
Study Completion (Actual)
December 17, 2021
Study Registration Dates
First Submitted
October 19, 2021
First Submitted That Met QC Criteria
October 19, 2021
First Posted (Actual)
October 27, 2021
Study Record Updates
Last Update Posted (Actual)
November 8, 2023
Last Update Submitted That Met QC Criteria
November 6, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2021H0118
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lens
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Ohio State UniversityCompletedContact LensUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
Clinical Trials on Precision1® Daily Disposable Contact Lens
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityAlcon ResearchCompletedContact Lens | Astigmatism of Both EyesUnited States
-
Coopervision, Inc.CompletedMyopiaUnited States
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
-
Coopervision, Inc.Active, not recruiting
-
Ohio State UniversityAlcon ResearchCompleted
-
Coopervision, Inc.Completed
-
University of ValenciaWrocław University of Science and TechnologyCompletedTear Film Hyperosmolarity
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States